Omnicare (NYSE:OCR) yesterday named interim CEO John Workman to the top job permanently to replace John Figueroa, who left in June. Workman had been CFO at the company, which supplies nursing homes with drugs, and so he'll be replaced by Robert Kraft. Omnicare also doubled its dividend to $0.14 a share and increased its buyback program by $350M, taking the total approved to $498M.